Profile of Tinea Corporis and Tinea Cruris in Dermatovenereology Clinic of Tertiery Hospital: A Retrospective Study
Profile of Tinea Corporis and Tinea Cruris in Dermatovenereology Clinic of Tertiery Hospital: A Retrospective Study
Profile of Tinea Corporis and Tinea Cruris in Dermatovenereology Clinic of Tertiery Hospital: A Retrospective Study
Selvia Yulianti Dwi Ratih Sanggarwati1, Manik Retno Wahyunitisari2, Linda Astari3,
Evy Ervianti3
1
Undergraduate of Medicine Program, Faculty of Medicine Universitas Airlangga
2
Departement of Microbiology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General
Academic Teaching Hospital, Surabaya, Indonesia
3
Departement of Dermatovenereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo
General Academic Teaching Hospital, Surabaya, Indonesia
ABSTRACT
Background: Tinea corporis and cruris are dermatophytes that infect the skin, and they are caused by Trichophyton sp.,
Microsporum sp., and Epidermophyton sp. Dermatophyte fungal-infect keratin-containing skin classified by the body’s
location, such as tinea corporis (skin besides haired area, body, hands, or feet) and tinea cruris (groin & perineal region).
Purpose: To evaluate the clinical profiles and treatments of tinea corporis and cruris at Dermatology and Venereology (DV)
outpatient clinic Dr. Soetomo General Academic Hospital in 2018. Methods: A retrospective-descriptive study based on
medical records of DV outpatient clinic Dr. Soetomo General Academic Hospital, Surabaya. Data collected from August to
December 2019. Tinea corporis and cruris profiles evaluation based on age, sex, occupation, precipitating factors, complaints,
illness duration, family history, lesion’s location and description, and therapy. Result: A total of 164 patients (35 tinea corporis,
76 tinea cruris, and 53 tinea corporis and cruris), predominantly female, age 46–55 years, came treatment less-than-a-month
cases, excessive sweating, itching, tinea corporis lesion’s location on the face and body, tinea cruris in groin, tinea corporis
and cruris on body and groin, erythematous macules, firm borders, active margins, scales, central healing, positive KOH 10–
20% examination, miconazole cream therapy 2%, griseofulvin therapy, griseofulvin oral and ketoconazole cream 2%
combination therapy. Discussion: Tinea corporis and cruris are common in females as their history and symptoms supported
by the characteristics of laboratory examination, the presence of hyphae in potassium hydroxide (KOH) 10–20%. Most patients
were prescribed with oral griseofulvin, especially in large lesions cases.
Keywords: tinea corporis, tinea cruris, potassium hydroxide 10–20%, retrospective descriptive research, Dr. Soetomo General
Academic Hospital.
Correspondence: Evy Ervianti, Department/SMF of Department of Dermatology and Venereology, Faculty of Medicine,
Universitas Airlangga/Dr. Soetomo General Academic Hospital, Jl. Mayjen Prof. Dr. Moestopo No. 6-8, Airlangga, Gubeng,
Surabaya, East Java 60286, Phone: 081332681513, E-mail : [email protected].
34
-
Original Article ology Clinic of Tertiery Hospital: A Retrospective Study
of the two diseases to decrease their prevalence and to firm boundaries, active margins, scales, central healing
finalise their diagnoses. (20.7%), potassium hydroxide (KOH) 10–20% tests
positive (80.4%), miconazole cream 2% (7%) topical
METHODS therapy, griseofulvin systemic therapy (69%), and
This was a retrospective descriptive study based combination therapy griseofulvin tablet and
on medical records at the Dermatology and ketoconazole cream 2% (3.04%).
Venereology Outpatient Clinic Dr. Soetomo General There were 76 tinea cruris patients (46.3%), 53
Academic Hospital. The data collection was carried out patients with tinea corporis and cruris (32.3%), and 35
in August–December 2019. The profile analysis of tinea corporis patients (21.4%). The sex distribution of
tinea corporis and cruris of outpatients was carried out the patients shows consisting of 67 males (40.9%) and
by completing records of the patient's age, sex, 97 females (59.1%). In terms of sex, there were 29 tinea
occupation, trigger factors, main complaints, length of corporis male patients (74.3%), 46 tinea cruris female
illness, family history, location of the lesion, patients (60.5%), and 28 tinea corporis and cruris male
description of the lesion, investigations, and therapy. patients (52.8 %).
This study has received ethical clearance from the The highest prevalence tinea corporis was under
Health Research Ethics Committee of Dr. Soetomo the middle-old age group, which was 56–65 years old,
General Academic Hospital Surabaya No. as many as 9 patients (25.7%). The youngest tinea
1517/KEPK/IX/2019. The medical records of tinea corporis patient was 1 year old, and the oldest was 69
corporis and cruris patients were then be grouped based years old. The tinea cruris patients indicated that the
on those criteria and presented in diagrams and tables. majority were the youngest-old group, namely 17
patients (22.4%). The youngest patient of tinea cruris
RESULT patients was 5 months and the oldest was 72 years. The
A total of 164 medical records were obtained, sample of tinea corporis and cruris patients showed that
consisting of 35 tinea corporis patients, 76 tinea cruris the largest age group was the youngest-old and early
patients, and 53 tinea corporis and cruris tinea patients. adult categories, namely 12 patients (22.6%). The
Of the 164 patients, most of the patients were females youngest patient in the tinea corporis and cruris group
(59.1%), under the age group of 46–55 years (20.7%), was 3 years old while the oldest was 117 years.
private employee (38.4%), came for therapy when the Most of the patients worked as private employees.
duration of illness was less than 1 month (29.2%), no There were 14 tinea corporis patients (40%), 26 tinea
family history (71.3%), excessive sweating as the cruris patients (34.2%), and 23 patients (43.4%) with
triggering factor (43.3%), itchiness as the main tinea corporis and cruris. Figure 1 shows that most of
complaint (89.6%), the location of tinea corporis the patients had excessive sweating, and 10 of them
lesions on the face and body (22.9%), tinea cruris in the (28.6%) had tinea corporis, 34 of them (44.7%) had
groin (55.3%), and tinea corporis and cruris on the tinea cruris, and 27 of them (50.9%) had tinea corporis
body and groin (26.4%), erythematous macular lesions, and cruris.
35
Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology Vol. 33 / No. 1 / April 2021
Most the chief complaints are itchiness, tinea (22.9%). Location of tinea cruris cases located on the
corporis 31 patients (88,6%), tinea cruris 66 patients groin, as observed in 42 patients (55.3%). Location of
(86,8%), tinea corporis and cruris are 50 patients tinea corporis and cruris were located in the trunk and
(94,3%). The location of lesion for tinea corporis groin, as observed in 14 patients (26.4%).
located in the face and body as observed in 8 patients
Topical treatment
Ketoconazole 2% cream 3 (8.6%)
Miconazole 2% cream 4 (11.4%)
Combination treatment 2 (5.7%)
No topical treatment 25 (71.4%)
No data 1 (2.9%)
Combination treatment
Griseofulvin tablet and ketoconazole 2% cream 3 (8.6%)
Griseofulvin tablet and miconazole 2% cream 3 (8.6%)
No data 1 (2.9%)
No combination treatment 28 (80%)
The most clinical features of tinea corporis scales, central healing, as observed in 24 patients
lesions were erythematous macules, firm borders, (31.6%). Tinea corporis and cruris lesions were
active margins, scales, central healing, as observed in erythematous macules, firm borders, active margins,
5 patients (14.3%). Tinea cruris lesions were scales, central healing, as observed in 5 patients
erythematous macules, firm borders, active margins, (9.4%). Duration of illness of tinea corporis and cruris
36
-
Original Article ology Clinic of Tertiery Hospital: A Retrospective Study
patients sought treatment in less than 1 month after the tablet and ketoconazole 2% cream, and 3 patients
illness started, consisting of 9 tinea corporis patients (8.6%) received a combination of griseofulvin tablet
(25.7%), 26 tinea cruris patients (34.2%), and 13 and miconazole 2% cream. Table 4 shows that the most
patients (24.5%) with both tinea corporis and cruris. prescribed systemic drug was griseofulvin tablets, as
Table 1 shows that most of the patients had no family observed in 52 patients (68.4%). 2 patients (2.6%)
history of the disease, totalling 24 tinea corporis received topical therapy of ketoconazole 2% cream, 2
patients (68.6%), 61 tinea cruris patients (80.3%), 32 patients (2.6%) received miconazole 2% cream, and 4
patients (60.4%) with both tinea corporis and cruris. patients (5.3%) received a combination therapy of
Table 2 shows the KOH examination of tinea corporis griseofulvin tablet and urea 10% cream. Table 5 shows
showed 29 positive results (82.9%), 60 positive results that griseofulvin was the most used systemic drug, as
on tinea cruris, and 43 positive results on patients with observed in 38 patients (71.7%). The most used topical
tinea corporis and tinea cruris (81.1%). Table 3 shows therapy was urea 10% cream, miconazole 2% cream,
that most patients received systemic therapy with and ketoconazole 2% cream, with 2 patients (3.8%)
griseofulvin, as observed in 21 patients (60%). each. The most used combination therapy was
The most used topical therapy was miconazole griseofulvin tablet with ketoconazole 2% cream and
2% cream, as observed in with 4 patients (11.4%) each. griseofulvin tablet with miconazole 2% cream, which
6 patients received combined therapy of griseofulvin 1 patient (1.9%) each.
Table 4. The treatment of tinea cruris Table 5. The treatment of tinea corporis and tinea
Treatment Total (%) cruris
Systemic treatment Treatment Total (%)
Griseofulvin tablet 52 (68.4%) Systemic treatment
Griseofulvin tablet and 4 (5.3%) Griseofulvin tablet 38 (71.7%)
cetirizine tablet Griseofulvin tablet and cetirizine 3 (5.7%)
Griseofulvin tablet and 1 (1.3%) tablet
loratadine tablet Griseofulvin tablet and 1 (1.9%)
Griseofulvin tablet and vitamin 2 (2.6%) erythromycin tablet
B complex tablet Ketoconazole tablet 2 (3.8%)
Griseofulvin tablet and 1 (1.3%) Natrium diclofenac tablet, 1 (1.9%)
chlorpheniramine tablet 4 mg thiamine tablet, and griseofulvin
Combination treatment 5 (6.6%) tablet
No systemic treatment 6 (7.9%) No systemic treatment 4 (7.5%)
No data 5 (6.6%) No data 4 (7.5%)
37
Berkala Ilmu Kesehatan Kulit dan Kelamin – Periodical of Dermatology and Venereology Vol. 33 / No. 1 / April 2021
38
-
Original Article ology Clinic of Tertiery Hospital: A Retrospective Study
to rule out the differential diagnosis between tinea Clinico-Mycological Study. J Med Sci Clin Res
corporis and pityriasis versicolor.13 Sabouraud 2017; 05(03): 19488-94.
Dextrose Agar (SDA) is the most commonly used 2. Craddock LN, Schieke SM. Superficial Fungal
isolation medium for dermatophytes, and it serves as Infection. In: Kang S, Amagai M, Bruckner AL,
the medium that forms the basis for most of the Enk AH, Margolis DJ, McMichael AJ, et al.,
morphological descriptions of fungi. The most editors. Fitzpatrick’s Dermatology. 9th Edition.
important examination was KOH because it is cheap New York: McGraw-Hill Education; 2019. p.
and fast in confirming dermatophytosis.2 On those 2925-51.
bases, the SDA culture examination was used to 3. Hayette M, Sacheli R. Dermatophytosis, Trends in
identify fungal species is only carried out for certain Epidemiology and Diagnostic Approach. Curr
cases, such as patients with extensive lesions, patients Fungal Infect Rep 2015;9(3):164-79.
with immunocompromised conditions, or lesions 4. Mahajan R, Sahoo A. Management of tinea
incompatible with tinea corporis or tinea cruris but corporis, tinea cruris, and tinea pedis: A
positive KOH results.14 comprehensive review. Indian Dermatol Online J
Griseofulvin was the main therapy of choice in 2016; 7(2): 77-86.
cases of tinea corporis and cruris, and it was the most 5. Leung A, Lam J, Leong K, Hon K. Tinea corporis:
frequently administered drug in patients with extensive an updated review. Drugs Context 2020; 9: 1-12.
lesions or cases where topical therapy resulted in no 6. Oninla OA, Oninla SO. Superficial Mycoses in
improvement. In addition, miconazole 2% cream and Relation to Age and Gender. Br J Med Med Res
ketoconazole 2% cream were the most used topical 2016; 13(5): 1-10.
therapy. This was in accordance with the PERDOSKI 7. Oktaviana N, Kawilarang AP, Damayanti. Patient
Clinical Practice Guide. The indication for topical Profile Of Tinea Corporis In Dr. Soetomo General
therapy is that if the lesion is not extensive and light, Hospital, Surabaya From 2014 To 2015. Jurnal
and the indication for systemic therapy is that if the Berkala Epidemiologi 2018; 6(3): 200-8.
lesion is extensive or more inflamed, often recurs and 8. Madhavi S, Rama Mao M, Jyothsna K.
does not heal with adequate topical drugs or Mycological study of Dermatophytosis in rural
recalcitrant forms.12,15 population. Ann Biol Res. 2011; 2(3): 88-93.
From the dermatophytosis research in the 9. Devy D, Ervianti E. Studi Retrospektif:
Mycology Division of Dermatology and Venereology Karakteristik Dermatofitosis. Berkala Ilmu
Outpatient Clinic Dr. Soetomo General Academic Kesehatan Kulit dan Kelamin 2018; 30(1): 66-72.
Hospital Surabaya conducted an overview of new cases 10. Sondakh CE, Pandaleke TA, Mawu FO. Profil
of dermatophytosis in the Mycology Division of dermatofitosis di Poliklinik Kulit dan Kelamin
Dermatology and Venereology Outpatient Clinic Dr. RSUP Prof. Dr. RD Kandou Manado periode
Soetomo General Academic Hospital Surabaya in the Januari–Desember. e-CliniC 2016; 4(1): 1-7.
previous year tended to decline. The therapy that is 11. Yuwita W, Ramali LM, Miliawati R. Karakteristik
often used in dermatophytosis is oral/systemic Tinea Kruris dan/atau Tinea Korporis di RSUD
griseofulvin which in general is in accordance with the Ciamis Jawa Barat. Berkala Ilmu Kesehatan Kulit
Clinical Practice Guidelines that apply in Mycology dan Kelamin 2016; 28(2): 42-51.
Division of Dermatology and Venereology Outpatient 12. Siswati AS, Ervianti E. Dermatologi Infeksi. In:
Clinic Dr. Soetomo General Academic Hospital Bramono K, Suyoso S, Indriatmi W, Ramali L,
Surabaya, with a fairly good recovery rate. Filling in Widaty S, Ervianti E, editors. Dermatomikosis
data using medical records is quite complete by filling Superfisialis. 2nd ed. Jakarta: Badan Penerbit FK
in complete patient data when taking anamnesis on the UI; 2013. p. 58-69.
category of identity, main complaint, length of illness, 13. Fuller LC, Barton RC, Mohd Mustapa MF,
family history, trigger factors, location of lesions, Proudfoot LE, Punjabi SP, Higgins EM. British
supporting laboratories, and therapy will make Association of Dermatologists' guidelines for the
diagnosis easier, facilitate patient treatment, and management of tinea capitis 2014. Br J Dermatol
complete data collection. 2014; 171(3): 454-63.
14. Poluri LV, Indugula JP, Kondapaneni SL.
REFERENCES Clinicomycological Study of Dermatophytosis in
1. Verma S, Verma G, Sharma V, Bhagra S, Negi A, South India. J Lab Physicians 2015; 7(2): 84-9.
Tegta GR. Current Spectrum of Dermatophytosis in 15. Yossela T. Diagnosis and Treatment of Tinea
a Tertiary Care Hospital of North India – A 6-Year cruris. J MAJORITY. 2015; 4(2): 122-8.
39